Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 298
Selected: 0
NCT IDTitle
NCT02828462Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
NCT00418327Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT02997358Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
NCT07131163Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection
NCT07436312Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
NCT03285230The French E3N Prospective Cohort Study
NCT02115165A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors
NCT03314324A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer
NCT06902883Study on the Effectiveness and Comfort of Innovative Solutions for the Internal Transport of Patients in Wheelchairs in a Hospital Setting
NCT00162656Treatment of Mature B-cell Lymphoma/Leukaemia
NCT04775121Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia
NCT03519048Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
NCT03984318Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT06781996A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
NCT05874063Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
NCT00552149Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
NCT01557114Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma
NCT01268202Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis
NCT02488369Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
NCT07483983Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
NCT03010553Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT02215720Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors
NCT04276376Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors
NCT02672527Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma
NCT02008734Randomized Phase II Study to Assess PD 0332991 in Breast Cancer
NCT02025881Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
NCT00433706Image Guided Radiation Therapy For Prostate Cancer
NCT01834950Identification of Early Markers of Response and Resistance to Trastuzumab
NCT00544349Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT02679963Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
NCT06479057PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy
NCT00162812Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin
NCT03356535Metabolic Signature of Healthy Lifestyle and HCC
NCT00370240Chlorhydrate of Ropivacaine and Breast Cancer Surgery
NCT04932525Gustave Roussy Cancer Profiling
NCT00180908Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
NCT00346645A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer
NCT03613194Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT01706016Local Treatment by Thermic Destruction of Primitive Breast Cancer
NCT01864772Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC
NCT01857453Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
NCT07001618Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
NCT02666690Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast
NCT03614936Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck
NCT06642844Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
NCT05890781Engineering Immune Organoids to Study Pediatric Cancer
NCT00367861Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance
NCT07303387Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
NCT00180921Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck